Viewing Study NCT05870761


Ignite Creation Date: 2025-12-24 @ 12:05 PM
Ignite Modification Date: 2025-12-27 @ 10:08 PM
Study NCT ID: NCT05870761
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-20
First Post: 2023-05-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma
Sponsor: Casey Cosgrove
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module